Updated Jul 16, 2026
WIERENGA WENDELL has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.63M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | CRNX | Crinetics Pharmaceuticals, Inc. | A — Grant or award | 5.9K | $0.00 | |
| 2026-05-27 | CYTK | CYTOKINETICS INC | A — Grant or award | 2.9K | $0.00 | |
| 2026-05-05 | CYTK | CYTOKINETICS INC | S — Open-market sale | 4.0K | $75.00 | $302K |
| 2026-05-05 | CYTK | CYTOKINETICS INC | M — Option exercise | 4.0K | $12.40 | $50K |
| 2026-04-15 | CYTK | CYTOKINETICS INC | A — Grant or award | 95 | $65.37 | $6K |
| 2026-01-16 | CYTK | CYTOKINETICS INC | A — Grant or award | 98 | $63.44 | $6K |
| 2025-12-23 | CYTK | CYTOKINETICS INC | S — Open-market sale | 20.0K | $66.14 | $1.32M |
| 2025-12-23 | CYTK | CYTOKINETICS INC | M — Option exercise | 20.0K | $7.61 | $152K |
WIERENGA WENDELL is a corporate insider — currently tracked as Director of Crinetics Pharmaceuticals, Inc. (CRNX). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.63M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WIERENGA WENDELL profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.